Harrow Health
Price & Volume
Stats
See moreOpen | $28.80 |
Previous Close | $28.54 |
Day Range | $28.39-$29.49 |
52W Range | $26.96-$54.85 |
Market Cap | $1B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $275.5M |
Revenue Growth (YoY) | 10.9% |
Gross Profit (12 Mos) | $201.9M |
Diluted EPS | -$0.99 |
News
See moreYahoo Finance • 3 months ago
Harrow (HROW): Strong Product Momentum Meets A Steep H2 Revenue Target
Yahoo Finance • 3 months ago
Harrow Q2 Earnings Call Highlights
Yahoo Finance • 3 months ago
Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026
Yahoo Finance • 4 months ago
Harrow Announces Commercial Launch of BYOOVIZ® in the United States
About
CEO | Mr. Mark L. Baum J.D. |
CFO | Mr. Andrew R. Boll C.F.A., C.M.A. |
Address | 1A Burton Hills Boulevard, Nashville, TN, United States, 37215 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 373 |